Axa’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,700
| Closed | -$245K | – | 1190 |
|
|
2023
Q1 | $245K | Buy |
+2,700
| New | +$245K | ﹤0.01% | 1049 |
|
|
2022
Q4 | – | Sell |
-12,600
| Closed | -$317K | – | 1237 |
|
|
2022
Q3 | $317K | Buy |
+12,600
| New | +$317K | ﹤0.01% | 1030 |
|
|
2020
Q3 | – | Sell |
-2,900
| Closed | -$452K | – | 1371 |
|
|
2020
Q2 | $452K | Sell |
2,900
-2,400
| -45% | -$374K | ﹤0.01% | 1081 |
|
|
2020
Q1 | $765K | Buy |
+5,300
| New | +$765K | ﹤0.01% | 899 |
|
|
2019
Q2 | – | Sell |
-4,800
| Closed | -$410K | – | 1380 |
|
|
2019
Q1 | $410K | Buy |
+4,800
| New | +$410K | ﹤0.01% | 1133 |
|